mutLBSgeneDB |
Gene summary for ALPP |
Gene summary |
Basic gene Info. | Gene symbol | ALPP |
Gene name | alkaline phosphatase, placental | |
Synonyms | ALP|PALP|PLAP|PLAP-1 | |
Cytomap | UCSC genome browser: 2q37 | |
Type of gene | protein-coding | |
RefGenes | NM_001632.3, | |
Description | Regan isozymealkaline phosphatase Regan isozymealkaline phosphatase, placental typealkaline phosphomonoesteraseglycerophosphataseplacental alkaline phosphatase 1 | |
Modification date | 20141207 | |
dbXrefs | MIM : 171800 | |
HGNC : HGNC | ||
Ensembl : ENSG00000163283 | ||
Vega : OTTHUMG00000133255 | ||
Protein | UniProt: P05187 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ALPP | |
BioGPS: 250 | ||
Pathway | NCI Pathway Interaction Database: ALPP | |
KEGG: ALPP | ||
REACTOME: ALPP | ||
Pathway Commons: ALPP | ||
Context | iHOP: ALPP | |
ligand binding site mutation search in PubMed: ALPP | ||
UCL Cancer Institute: ALPP | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0016311 | dephosphorylation | 2017684 |
Top |
Ligand binding site mutations for ALPP |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | R319 | R319C | STAD | 2 | D307 | P308L | OV | 1 | D64 | M66I | SKCM | 1 | D338 | R336C | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for ALPP |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | D64 | M66I | -0.77895814 | D338 | R336C | -0.47727031 | D307 | P308L | -0.27557205 | R319 | R319C | -0.027690504 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for ALPP from PDB |
PDB ID | PDB title | PDB structure | 1EW2 | CRYSTAL STRUCTURE OF A HUMAN PHOSPHATASE |
Top |
Differential gene expression and gene-gene network for ALPP |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for ALPP |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for ALPP |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Gene-centered drug-gene interaction network |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Experimental | DB08413 | METHYL-PHOSPHONIC ACID MONO-(4-NITRO-PHENYL) ESTER | Small molecule |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of ALPP go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS |
Top |
Conservation information for LBS of ALPP |
Multiple alignments for P05187 in multiple species |
LBS | AA sequence | # species | Species |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |